A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epileps...
A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy
About this item
Full title
Author / Creator
Riva, Antonella , Roberti, Roberta , D'Onofrio, Gianluca , Vari, Maria Stella , Amadori, Elisabetta , De Giorgis, Valentina , Cerminara, Caterina , Specchio, Nicola , Pietrafusa, Nicola , Tombini, Mario , Assenza, Giovanni , Cappanera, Silvia , Marini, Carla , Rasmini, Paolo , Veggiotti, Pierangelo , Zara, Federico , Russo, Emilio and Striano, Pasquale
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Response to antiseizure medications (ASMs) can be influenced by several gene polymorphisms, causing either lower efficacy or higher occurrence of adverse drug reactions (ADRs). We investigated the clinical utility of salivary pharmacogenomic testing on epilepsy patients. A commercialized pharmacogenomic salivary test was performed in a cohort of ep...
Alternative Titles
Full title
A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy
Authors, Artists and Contributors
Author / Creator
Roberti, Roberta
D'Onofrio, Gianluca
Vari, Maria Stella
Amadori, Elisabetta
De Giorgis, Valentina
Cerminara, Caterina
Specchio, Nicola
Pietrafusa, Nicola
Tombini, Mario
Assenza, Giovanni
Cappanera, Silvia
Marini, Carla
Rasmini, Paolo
Veggiotti, Pierangelo
Zara, Federico
Russo, Emilio
Striano, Pasquale
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_89748850918e4af5aae8b4008c9d68b6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89748850918e4af5aae8b4008c9d68b6
Other Identifiers
ISSN
2470-9239
E-ISSN
2470-9239
DOI
10.1002/epi4.12717